{"id":25644,"date":"2025-06-06T10:02:24","date_gmt":"2025-06-06T08:02:24","guid":{"rendered":"https:\/\/www.izb-online.de\/grosse-buehne-dpa-berichtet-ueber-izb-strat-ups\/"},"modified":"2025-06-06T10:14:55","modified_gmt":"2025-06-06T08:14:55","slug":"in-the-spotlight-dpa-features-izb-start-ups","status":"publish","type":"post","link":"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/in-the-spotlight-dpa-features-izb-start-ups\/","title":{"rendered":"In the Spotlight: dpa Features IZB Start-ups"},"content":{"rendered":"

[vc_row el_class=”gco-magazine-container”][vc_column el_class=”bildspalte”][vc_row_inner][vc_column_inner offset=”vc_col-lg-12 vc_col-md-12″][vc_column_text css=”” el_class=”gco-magazine–title”]<\/p>\n

In the Spotlight: dpa Features IZB Start-ups<\/strong><\/h1>\n

[\/vc_column_text][vc_column_text css=”” el_class=”gco-magazine-lead”]Our founders are doing impressive work \u2013 and they deserve to be seen and heard. Of course, no single media outlet can capture the full spectrum of innovation. That\u2019s why we\u2019re especially pleased that the German Press Agency (dpa) visited and profiled five IZB companies as representatives of our broader community.[\/vc_column_text][vc_column_text css=”” el_class=”gco-magazine–post-date”]June, 2025[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”two-columns” el_id=”corona-ausblenden”][vc_column_inner el_class=”bild-zwei-spalten-links”][vc_single_image image=”6283″ img_size=”full”][vc_column_text el_class=”gco-magazine-copyright”]\u00a9 Pieris[\/vc_column_text][vc_column_text el_class=”gco-magazine-picture-discription”]The Lungs[\/vc_column_text][vc_single_image image=”6285″ img_size=”full”][vc_column_text el_class=”gco-magazine-copyright”]\u00a9 Pieris[\/vc_column_text][vc_column_text el_class=”gco-magazine-picture-discription”]Stephen S. Yoder<\/strong>, CEO, Pieris Pharmaceuticals Inc.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_single_image image=”25639″ img_size=”full” css=””][vc_column_text css=”” el_class=”gco-magazine-copyright” el_id=”corona-ausblenden”]\u00a9 Adivo GmbH[\/vc_column_text][vc_column_text css=”” el_class=”gco-magazine-picture-discription” el_id=”corona-ausblenden”]Dr. Kathrin Ladetzki-Baehs, Gr\u00fcnderin und Gesch\u00e4ftsf\u00fchrerin von adivo GmbH; Dr. Markus Waldhuber, Gr\u00fcnder und Gesch\u00e4ftsf\u00fchrer adivo GmbH (v.ln.r.)[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine–quote” css=”.vc_custom_1749196757847{margin-top: 33px !important;}” el_id=”corona-ausblenden”][vc_column_inner][vc_column_text]<\/p>\n

\u201eUnser Team entwickelt mit gro\u00dfer Leidenschaft hochinnovative Therapeutika f\u00fcr Haustiere, um die Lebensqualit\u00e4t unserer vierbeinigen Gef\u00e4hrten und ihrer jeweiligen Besitzer deutlich zu verbessern. Wir freuen uns, heute mit einem so erfahrenen Partner bei der Entwicklung von therapeutischen Antik\u00f6rpern f\u00fcr Haustiere zusammenzuarbeiten, um die Innovation in der Tiergesundheit weiter voranzutreiben.\u201c<\/h6>\n

Dr. Kathrin Ladetzki-Baehs
\nGr\u00fcnderin und Gesch\u00e4ftsf\u00fchrerin, adivoG<\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine-container–copy” css=”.vc_custom_1591795890737{margin-top: 21px !important;}”][vc_column_inner][vc_column_text css=””]The article received wide media coverage \u2013 including features in S\u00fcddeutsche Zeitung<\/em>, Zeit online<\/em>, tz<\/em>, and on ntv<\/em>.<\/p>\n

Read more: www.zeit.de<\/a>[\/vc_column_text][vc_column_text css=”.vc_custom_1583761043671{background-color: #1e73be !important;}” el_class=”redaktionell”][\/vc_column_text][\/vc_column_inner][\/vc_row_inner]\n\n

\n
\n